Grand Pharmaceutical Group Limited 0512.HK
0512.HK
Grand Pharmaceutical Group Limited 3320.HK
China Resources Pharmaceutical Group Limited 3933.HK
The United Laboratories International Holdings Limited 0867.HK
China Medical System Holdings Limited 1513.HK
Livzon Pharmaceutical Group Inc. 1066.HK
Shandong Weigao Group Medical Polymer Company Limited 0013.HK
HUTCHMED (China) Limited 2096.HK
Simcere Pharmaceutical Group Limited 9989.HK
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. 9606.HK
Duality Biotherapeutics, Inc.
Grand Pharmaceutical Group Limited 3320.HK
China Resources Pharmaceutical Group Limited 3933.HK
The United Laboratories International Holdings Limited 0867.HK
China Medical System Holdings Limited 1513.HK
Livzon Pharmaceutical Group Inc. 1066.HK
Shandong Weigao Group Medical Polymer Company Limited 0013.HK
HUTCHMED (China) Limited 2096.HK
Simcere Pharmaceutical Group Limited 9989.HK
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. 9606.HK
Duality Biotherapeutics, Inc.
Performance
| Periode | 0512.HK | 3320.HK | 3933.HK | 0867.HK | 1513.HK | 1066.HK | 0013.HK | 2096.HK | 9989.HK | 9606.HK |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 46.94 % | -2.67 % | 3.63 % | 78.64 % | 25.34 % | 0.54 % | 7.51 % | 71.02 % | 21.91 % | 52.19 % |
| YTD | 77.61 % | -13.97 % | 7.35 % | 76.95 % | 20.67 % | 26.71 % | 1.54 % | 91.52 % | 35.49 % | 63.02 % |
| 1Y | 74.57 % | -19.25 % | 23.26 % | 54.29 % | 15.71 % | 11.22 % | -27.78 % | 100.61 % | 23.35 % | 63.02 % |
| 3Y | 111.11 % | -18.84 % | 275.43 % | 40.13 % | 53.19 % | -53.83 % | 76.00 % | 48.53 % | -1.13 % | 63.02 % |
| 5Y | 26.08 % | 21.23 % | 92.67 % | 53.75 % | -10.50 % | -63.10 % | -60.60 % | 19.31 % | -62.48 % | 63.02 % |
| 10Y | 2 264.83 % | -47.39 % | 200.69 % | 23.63 % | 77.92 % | 0.36 % | -60.60 % | 19.31 % | -70.39 % | 63.02 % |
| From the beginning | 3 487.58 % | -47.39 % | 296.98 % | 336.21 % | 81.41 % | 3 071.43 % | -60.60 % | 19.31 % | -70.39 % | 63.02 % |